Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2019 September;85(9) > Minerva Anestesiologica 2019 September;85(9):943-50



Opzioni di pubblicazione
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo


ORIGINAL ARTICLE   Free accessfree

Minerva Anestesiologica 2019 September;85(9):943-50

DOI: 10.23736/S0375-9393.19.13420-7


lingua: Inglese

Automated measurement of neutrophil CD64 expression for diagnosing sepsis in critically ill patients

Claire THIRIET 1, 2, Khaoula MAHJOUB 1, 2, Guilhem COURTE 1, 2, Pierre LABROCA 1, 2, Aurélie CRAVOISY 1, 2, Jérémie LEMARIE 1, 2, Marie CONRAD 1, 2, Lionel NACE 1, 2, Pierre-Edouard BOLLAERT 1, 2, Sébastien GIBOT 1, 2

1 Service of Reanimation, Central Hospital, Nancy, France; 2 Inserm U1116, Faculty of Medicine, University of Lorraine, Nancy, France

BACKGROUND: Although early identification of sepsis improves outcome, prompt and correct diagnostic remains often challenging. The expression of the high affinity immunoglobulin-Fc fragment receptor I CD64 on neutrophils is upregulated during acute inflammation. We here aimed at determining the usefulness of its rapid measurement in diagnosing sepsis.
METHODS: Seventy-two consecutive patients were enrolled upon admission to Intensive Care Unit within a two-month period. Sequential determination of serum C-reactive protein (CRP) and procalcitonin (PCT) concentrations was obtained. The neutrophil CD64 index was measured using Accellix-CD64® device, an in vitro diagnosis system allowing for an automatic and standardized measure.
RESULTS: Serum concentrations of CRP and PCT as well as the neutrophil CD64 index were higher in septic patients compared to all others (P<0.05 for the three markers). Only CD64 index was an independent predictor of sepsis, though with modest sensitivity and specificity (78% and 70%, respectively). Repeat determination of CD64 index at day 2 correctly classified 85% of patients.
CONCLUSIONS: This prospective study demonstrates the moderate performance of the neutrophil CD64 index, assessed through the Accellix-CD64® device, in diagnosing sepsis in the critically ill patient. However, repeat measurements improve its accuracy and may help to predict ICU-acquired infections.

KEY WORDS: Sepsis; Diagnosis; Biomarkers; Procalcitonin; IgG receptors

inizio pagina